CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: February 3, 2005
Result type: Reports
Project Number: SR0032-000
Product Line: Reimbursement Review

Generic Name: Laronidase

Brand Name: Aldurazyme

Manufacturer: Genzyme Canada

Therapeutic Area: Mucopolysarccharidosis 1 (MPS 1), Hurler, Hurler-Scheie, Scheie

Indications: Mucopolysaccharidosis 1 (MPS 1), Hurler, Hurler-Scheie, Scheie

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: July 14, 2005

Recommendation Type: Do not list